Infective dermatitis after treatment with secukinumab

Clin Exp Dermatol. 2022 Jan;47(1):151-153. doi: 10.1111/ced.14844. Epub 2021 Sep 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Dermatitis / microbiology*
  • Female
  • Humans
  • Psoriasis / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • secukinumab